B-cell lymphoma

May 02, 2018

More Progress on LLS-Supported CAR T-cell Immunotherapy, A Revolutionary Approach to Cancer Treatment

Mar 16, 2018

Diffuse Large B Cell Lymphoma Drug Market, 2024 - 84 Drugs in the Clinical Pipeline

Jan 17, 2018

Curis Announces Initiation of Phase 1 Trial of CA-4948, a Small Molecule Inhibitor of IRAK4 Kinase in Patients with Lymphoma

Dec 01, 2017

Xynomic Pharma Initiates Ph 1/2 Trial Combining Abexinostat with Ibrutinib in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (r/r DLBCL) and Mantle Cell Lymphoma (r/r MCL)

Oct 18, 2017

FDA Approves Second LLS-Supported CAR T-cell Immunotherapy, A Revolutionary Approach to Cancer Treatment

Oct 18, 2017

FDA approves CAR-T cell therapy to treat adults with certain types of large B-cell lymphoma

Aug 08, 2017

More than 20 Years Helping Cancer Patients and Saving Lives

Jun 24, 2017

European Hematology Association: Global Trial of the Efficacy and Safety of CTL019 in Adult Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma: An Interim Analysis of the JULIET Study

Jun 24, 2017

European Hematology Association: Clinical and Biologic Covariates of Outcomes in ZUMA-1: A Pivotal Trial of Axicabtagene Ciloleucel (axi-cel; KTE-C19) in Patients with Refractory Aggressive non-Hodgkin Lymphoma (NHL)

Jun 19, 2017

Hematologists to Discuss Breakthroughs in Blood Disorders in Madrid